P
Pacific Shuanglin Bio pharmacy Co Ltd
SZSE:000403
Pacific Shuanglin Bio pharmacy Co Ltd
SZSE:000403
Price:
13.49
CNY
-1.1%
Market Closed
Market Cap:
¥12.8B
Relative Value
The Relative Value of one Pacific Shuanglin Bio pharmacy Co Ltd stock under the Base Case scenario is 17.27 CNY. Compared to the current market price of 13.49 CNY, Pacific Shuanglin Bio pharmacy Co Ltd is Undervalued by 22%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
17.27
CNY
Undervaluation 22%
P
Multiples Across Competitors
Competitors Multiples
Pacific Shuanglin Bio pharmacy Co Ltd Competitors
Pacific Shuanglin Bio pharmacy Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
P
|
Pacific Shuanglin Bio pharmacy Co Ltd
SZSE:000403
|
12.8B CNY | 5.4 | 22.9 | 20.4 | 20.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
403.9B USD | 6.8 | 172.1 | 16.6 | 23.6 | |
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
326.4B USD | 462 374.5 | -2 631.9 | -2 377 | -2 377 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204.6B USD | 5.6 | 26.5 | 15.2 | 15.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.7B USD | 6.3 | 21.8 | 14.8 | 14.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.5B USD | 10.2 | 31 | 23.7 | 24.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.7B USD | 5.8 | 18.4 | 13.9 | 15.9 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR | 14.1 | 33.3 | 57 | 58.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70.5B AUD | 3.1 | 16.3 | 11.2 | 14 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
